The Pharmacology of Human Appetite: From Leptin to GLP-1 to Drug Targets
This review maps the complete pharmacology of human appetite — from leptin and hypothalamic circuits to gut peptides (GLP-1, PYY, CCK, ghrelin) — identifying the most promising drug targets for obesity treatment.
Quick Facts
What This Study Found
Human appetite is regulated by a multi-level system including adiposity signals (leptin, insulin), gut peptides (GLP-1, PYY, CCK, ghrelin), and hypothalamic neuropeptides (NPY, AgRP, POMC), with GLP-1 and PYY identified as the most druggable targets.
Key Numbers
How They Did This
review study examining glp-1 and neuropeptides.
Why This Research Matters
Advances understanding of glp-1, neuropeptides, weight-loss, receptor-signaling with translational implications.
The Bigger Picture
Contributes to the growing body of peptide research with implications for clinical development and therapeutic applications.
What This Study Doesn't Tell Us
Study-specific limitations apply; see abstract for details.
Questions This Raises
- ?Further research needed to confirm and extend these findings.
- ?Clinical translation and safety need evaluation.
- ?Optimal dosing and delivery require characterization.
Trust & Context
- Key Stat:
- Key finding Human appetite is regulated by a multi-level system including adiposity signals (leptin, insulin), gut peptides (GLP-1, PYY, CCK, ghrelin), and hypoth
- Evidence Grade:
- moderate evidence from review study design.
- Study Age:
- Published in 2004.
- Original Title:
- The pharmacology of human appetite expression.
- Published In:
- Current drug targets, 5(3), 221-40 (2004)
- Authors:
- Halford, Jason C G(3), Cooper, Gillian D, Dovey, Terence M(2)
- Database ID:
- RPEP-00921
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was the main focus of this study?
The Pharmacology of Human Appetite: From Leptin to GLP-1 to Drug Targets
What was discovered?
This review maps the complete pharmacology of human appetite — from leptin and hypothalamic circuits to gut peptides (GLP-1, PYY, CCK, ghrelin) — identifying the most promising drug targets for obesity treatment.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00921APA
Halford, Jason C G; Cooper, Gillian D; Dovey, Terence M. (2004). The pharmacology of human appetite expression.. Current drug targets, 5(3), 221-40.
MLA
Halford, Jason C G, et al. "The pharmacology of human appetite expression.." Current drug targets, 2004.
RethinkPeptides
RethinkPeptides Research Database. "The pharmacology of human appetite expression." RPEP-00921. Retrieved from https://rethinkpeptides.com/research/halford-2004-the-pharmacology-of-human
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.